Brief: Captor Therapeutics Informs About Nomination Of Candidate For CPT-6281 Drug Under CT-01 Project
08/08/2022 16:31
Aug 8 (Reuters) - Captor Therapeutics SA CTXP.WA :
* INFORMS ABOUT NOMINATION OF CANDIDATE FOR CPT-6281 DRUG
UNDER
CT-01 PROJECT AND START OF CTA/IND-ENABLING STUDIES
Source text for Eikon: ID:nEM364NVMa
Further company coverage: CTXP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Captor Therapeutics SA
See all newsBrief: Captor Therapeutics To Issue 8934 Series Z Shares For Incentive Programme Purpose
Brief: Captor Therapeutics Q1 Net Loss At 11.4 Million Zlotys
Brief: Captor Therapeutics FY Net Loss At 42.0 Million Zlotys
Brief: Captor Therapeutics To Sell 800,000 Y Series Shares At 82 Zlotys/Shr
Brief: Captor Therapeutics Starts ABB Process For Up To 800,000 New Series Y Shares